Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase (produced by DSM 33700) (RONOZYME® WX (CT/L)) for all poultry species and all (DSM nutritional products ltd).

The additive RONOZYME® WX (CT/L) contains endo-1,4-beta-xylanase produced with a genetically modified strain of the filamentous fungus ; the additive is currently authorised for poultry for fattening, weaned piglets, pigs for fattening, lactating sows and laying hens. The applicant has requested to change the production strain, substituting strain DSM 26372 with DSM 33700, and to extend the use of the additive to all poultry species and all . RONOZYME® WX (CT/L), manufactured with the production strain DSM 33700, did not give rise to safety concerns with regard to the genetic modification of the production strain. No viable cells of the production strain nor its DNA were detected in an intermediate product representative of both final formulations of the additive. RONOZYME® WX (CT/L) was considered safe for all poultry species and all at the recommended inclusion levels. The use of RONOZYME® WX CT and L manufactured with the production strain DSM 33700 raised no concerns for consumers. RONOZYME® WX L is not an eye irritant; however, no conclusions could be drawn on the potential of RONOZYME® WX CT to be an eye irritant. Both formulations are not irritant to the skin, but due to the lack of data, the FEEDAP Panel was not able to conclude on the potential of both formulations of the additive to be skin sensitisers. Due to the proteinaceous nature of the active substance, the additive is considered a respiratory sensitiser. The additive manufactured by DSM 33700 raises no safety concerns for the environment. The additive has the potential to be efficacious in all poultry species and all at 100 and 200 FXU/kg complete feed, respectively.